Core Laboratories (CLB) EBIAT (2022 - 2025)
Core Laboratories (CLB) has 4 years of EBIAT data on record, last reported at $14.2 million in Q3 2025.
- For Q3 2025, EBIAT rose 18.62% year-over-year to $14.2 million; the TTM value through Sep 2025 reached $34.4 million, up 27.8%, while the annual FY2024 figure was $32.2 million, 12.33% down from the prior year.
- EBIAT reached $14.2 million in Q3 2025 per CLB's latest filing, up from $12.6 million in the prior quarter.
- Across five years, EBIAT topped out at $22.8 million in Q2 2023 and bottomed at $69000.0 in Q1 2025.
- Average EBIAT over 4 years is $8.6 million, with a median of $8.3 million recorded in 2024.
- Peak YoY movement for EBIAT: soared 239.65% in 2024, then plummeted 98.02% in 2025.
- A 4-year view of EBIAT shows it stood at $6.5 million in 2022, then crashed by 66.09% to $2.2 million in 2023, then skyrocketed by 239.65% to $7.5 million in 2024, then surged by 90.64% to $14.2 million in 2025.
- Per Business Quant database, its latest 3 readings for EBIAT were $14.2 million in Q3 2025, $12.6 million in Q2 2025, and $69000.0 in Q1 2025.